Park IA - Search Results

1

Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia.

No JH, Jo H, Kim SH, Park IA, Kang D, Han SS, Kim JW, Park NH, Kang SB, Song YS. No JH, et al. Among authors: park nh, park ia. Ann N Y Acad Sci. 2009 Aug;1171:105-10. doi: 10.1111/j.1749-6632.2009.04891.x. Ann N Y Acad Sci. 2009. PMID: 19723043

2

Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia.

No JH, Jo H, Kim SH, Park IA, Kang D, Lee CH, Han SS, Kim JW, Park NH, Kang SB, Song YS. No JH, et al. Among authors: park nh, park ia. Ann N Y Acad Sci. 2009 Aug;1171:100-4. doi: 10.1111/j.1749-6632.2009.04898.x. Ann N Y Acad Sci. 2009. PMID: 19723042

3

Cyclooxygenase-2 expression in cervical intraepithelial neoplasia.

Kim K, Jeon YT, Park IA, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Kim K, et al. Among authors: park nh, park ia. Ann N Y Acad Sci. 2009 Aug;1171:111-5. doi: 10.1111/j.1749-6632.2009.04724.x. Ann N Y Acad Sci. 2009. PMID: 19723044

4

VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.

Kim YH, Kim MA, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB. Kim YH, et al. Among authors: park nh, park ia, park wy. Gynecol Oncol. 2010 Nov;119(2):232-6. doi: 10.1016/j.ygyno.2010.07.035. Epub 2010 Aug 24. Gynecol Oncol. 2010. PMID: 20797778

5

Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer.

Kim YH, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB. Kim YH, et al. Among authors: park nh, park ia, park wy. Int J Gynecol Cancer. 2011 Jan;21(1):2-7. doi: 10.1097/IGC.0b013e318204f6e6. Int J Gynecol Cancer. 2011. PMID: 21330825

6

Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.

Kim MH, Seo SS, Song YS, Kang DH, Park IA, Kang SB, Lee HP. Kim MH, et al. Among authors: park ia. Gynecol Oncol. 2003 Jul;90(1):83-90. doi: 10.1016/s0090-8258(03)00224-5. Gynecol Oncol. 2003. PMID: 12821346

7

Expression of mTOR protein and its clinical significance in endometrial cancer.

No JH, Jeon YT, Park IA, Kang D, Kim JW, Park NH, Kang SB, Song YS. No JH, et al. Among authors: park nh, park ia. Med Sci Monit. 2009 Oct;15(10):BR301-305. Med Sci Monit. 2009. PMID: 19789507

8

Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication.

Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Jeon YT, et al. Among authors: park nh, park ia. Cancer Lett. 2006 Aug 8;239(2):198-204. doi: 10.1016/j.canlet.2005.08.001. Epub 2005 Sep 15. Cancer Lett. 2006. PMID: 16168561

9

Influences of cyclooxygenase-1 and -2 expression on the radiosensitivities of human cervical cancer cell lines.

Jeon YT, Song YC, Kim SH, Wu HG, Kim IH, Park IA, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Jeon YT, et al. Among authors: park nh, park ia. Cancer Lett. 2007 Oct 18;256(1):33-8. doi: 10.1016/j.canlet.2007.05.008. Epub 2007 Jun 29. Cancer Lett. 2007. PMID: 17601662

10

Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer.

Han SS, Cho JY, Park IA, Park SK, Jeon YT, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Han SS, et al. Among authors: park nh, park ia, park sk. Med Sci Monit. 2008 Apr;14(4):CR183-9. Med Sci Monit. 2008. PMID: 18376345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters